CVS Health (CVS)
(Delayed Data from NYSE)
$62.47 USD
+0.37 (0.60%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $62.49 +0.02 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth C Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, CVS Health Corporation has a market cap of $78.56B, which represents its share price of $62.10 multiplied by its outstanding shares number of 1.27B. As a large-cap company, CVS's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CVS 62.47 +0.37(0.60%)
Will CVS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CVS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CVS
3 Medical Stocks to Consider as Markets Take a Breather
Economy Heating Up on PCE for June
CVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
PCE Comes in Warmer Than Expected
CVS Stock Up on Q2 Earnings & Revenue Beat, '25 EPS View Raised
CVS Health (CVS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for CVS
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
5 Dividend Stocks With Solid Returns And More Growth Ahead
CVS Health (CVS): Morgan Stanley Raises Price Target to $82 | CVS Stock News
CVS Health (CVS) Target Price Boosted by BofA Following Strong Q2 Results
Barclays Raises Price Target on CVS to $80, Maintains Overweight Rating | CVS Stock News